Author

D. Pitt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:spatial domain detection· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

C. Park· 2 shared G. Ponath· 2 shared B. A. Lerner· 1 shared B. M. Segal· 1 shared D. A. Hafler· 1 shared D. DeBartolo· 1 shared E. Bull· 1 shared E. C. Swanson· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Park

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions

C. Park, G. Ponath, M. Levine-Ritterman, E. Bull, E. C. Swanson, P. L. De Jager, B. M. Segal, D. Pitt

This study identifies distinct myeloid and astrocyte phenotypes in MS lesions using imaging mass cytometry and shows their spatial distribution and interactions.

bioRxiv · Jun 23, 2019Immunology

Differential expression of the T cell inhibitor TIGIT in Glioblastoma and Multiple Sclerosis

L. E. Lucca, B. A. Lerner, D. DeBartolo, C. Park, G. Ponath, K. Raddassi, D. A. Hafler, D. Pitt

The paper compares TIGIT expression in glioblastoma tumor-infiltrating T cells and multiple sclerosis lesions, finding higher TIGIT expression in GBM and suggesting anti-TIGIT therapy as a potential treatment.

bioRxiv · Mar 27, 2019 · PreprintImmunology